Ameritas Investment Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ameritas Investment Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-80	Closed	-$13.2K	–	1410
2021 Q1	$13.2K	Buy	+80	New	+$13.2K	﹤0.01%	1433
2020 Q2	–	Sell	-9	Closed	-$1K	–	989
2020 Q1	$1K	Buy	+9	New	+$1.16K	﹤0.01%	1667
2019 Q4	–	Sell	-9	Closed	-$1K	–	1180
2019 Q3	$1K	Buy	+9	New	+$1.21K	﹤0.01%	1567
2019 Q2	–	Sell	-9	Closed	-$1K	–	549
2019 Q1	$1K	Sell	9 -22	-71%	-$2.87K	﹤0.01%	897
2018 Q4	$4K	Buy	+31	New	+$4.6K	﹤0.01%	1273

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Company's JAZZ Position: Q2 2021 in Review

Ameritas Investment Company sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 80 shares — an estimated $13.2K sold.

Ameritas Investment Company first reported a position in JAZZ in Q4 2018 and held it in 5 quarters. The position peaked at $13.2K in Q1 2021. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

Ameritas Investment Company reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 80 Jazz Pharmaceuticals shares in Q2 2021, an estimated $13.2K.
Ameritas Investment Company first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 5 quarters.
Ameritas Investment Company's Jazz Pharmaceuticals position peaked at $13.2K in Q1 2021.
505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.